We aimed to assess how control measures during the coronavirus disease 2019 (COVID-19) pandemic affected the metabolic health of people with noncommunicable diseases when severe restrictions on movement and safety concerns prevented the use of traditional methods of health data collection. To identify study participants, we attempted to use hospital laboratory databases in Jamaica, Barbados, and Trinidad and Tobago.

Objective

To quantify the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) cases in Brazil from January 2013 to May 2023. 

Methods

A descriptive study was conducted on VAPP cases reported as events supposedly attributable to vaccination or immunization (ESAVI) following oral poliovirus vaccine (OPV) administration. VAPP cases were defined as acute flaccid paralysis (AFP) with isolation of vaccine-derived poliovirus in stool samples and persistence of motor deficits after 60 days. 

Objective

To establish baseline seroprevalence of soil-borne, waterborne, and foodborne diseases and to monitor diseases that are eliminated or on the path to elimination in the Paraguayan Chaco. 

Objective

To systematize and share knowledge and lessons learned from the implementation of follow-up vaccination campaigns in the Region of the Americas between 2003 and 2023. 

Objective

To analyze international health reform experiences to inform Chile’s health financing reform efforts. 

Methods

A scoping review methodology was used. Six countries that met inclusion criteria were used for the comparative analysis: Canada, Denmark, Estonia, France, Slovenia, and Spain. A profile was prepared for each country describing the financing system, the structures in charge of managing the public health insurance system, and the institution responsible for financing and its attributions regarding healthcare providers. 

The Manual for Surveillance of Events Supposedly Attributable to Vaccination or Immunization in the Region of the Americas represented one of the first steps toward building the regional system for surveillance of events supposedly attributable to vaccination or immunization (ESAVIs) and adverse events of special interest (AESIs). This manual establishes that, after notification and investigation of an event, a national committee of experts should classify the event in accordance with the World Health Organization (WHO) causality classification.

In May 2024, the Pan American Health Organization issued alerts of increased numbers of cases of Oropouche fever in non-Amazonian regions in Latin America. Following this, an association between Oropouche fever and Guillain–Barré syndrome was reported in three patients in Santiago de Cuba, Cuba. Neurological manifestations have rarely been described in relation to Oropouche virus infection. Previously, encephalitis and meningoencephalitis have been associated with Oropouche virus infection, but now the virus seems also to be associated with Guillain–Barré syndrome.